Skip to main content
About
Executive Team
Board of Directors
How We Operate
Quality
Capabilities
Locations
News
Products
Contract Manufacturing
Investors
Careers
Careers
Benefits
Available Positions
Application
Contact
Contact Us
Locations
News
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Investment Calculator
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Site Search
Normal
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
12/29/2015
ANI Pharmaceuticals Announces Launch of Flecainide Tablets
12/23/2015
ANI Pharmaceuticals Announces Launch of Nimodipine 30mg Capsules
12/17/2015
ANI Pharmaceuticals Announces FDA Approval of Polyethylene Glycol 3350 Powder for Oral Solution, 17mg/Scoopful
12/08/2015
ANI Pharmaceuticals Presents At Oppenheimer 26th Annual Healthcare Conference
11/03/2015
ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2015 Results and Highlights
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
11/02/2015
ANI Pharmaceuticals Announces Launch of Vancomycin Capsules
10/27/2015
ANI Pharmaceuticals Schedules Conference Call for Third Quarter and Year-to-Date 2015 Financial Results
10/16/2015
ANI Pharmaceuticals Announces Launch of Oxycodone Hydrochloride Oral Solution
10/13/2015
ANI Pharmaceuticals Appoints Peter A. Lankau to Its Board of Directors
10/05/2015
ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program
09/21/2015
ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75 Million
08/12/2015
ANI Pharmaceuticals and IDT Australia Enter Partnership to Commercialize US Generic Drug Products
08/04/2015
ANI Pharmaceuticals Reports 2nd Quarter 2015 Results
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
07/28/2015
ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results
07/27/2015
ANI Pharmaceuticals and Sofgen Announce FDA Approval of Nimodipine 30mg Capsules
07/13/2015
ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million
06/02/2015
ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL
05/15/2015
ANI Pharmaceuticals Presents at the UBS Global Healthcare Conference
05/13/2015
ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%
05/05/2015
ANI Pharmaceuticals Reports First Quarter 2015 Financial Results
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
04/28/2015
ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results
04/07/2015
ANI Pharmaceuticals Presents At 14th Annual Needham Healthcare Conference
03/31/2015
ANI Pharmaceuticals Announces the Launch of Propafenone Tablets
03/10/2015
ANI Pharmaceuticals Announces the Launch of Etodolac 200mg Capsules
03/05/2015
ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals
03/04/2015
ANI Pharmaceuticals To Present At 27th Annual ROTH Conference
02/19/2015
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results
Download
PDF format download (opens in new window)
Earnings Release Tables
PDF
PDF format download (opens in new window)
02/12/2015
ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2014 Financial Results
02/03/2015
ANI Pharmaceuticals Announces Appointment of Dr. David Sullivan to VP of Quality Operations
01/30/2015
ANI Pharmaceuticals Announces the Launch of Etodolac 300mg Capsules